GYPB
Glycophorin-B
Also known as: CD235b, GLPB_HUMAN, GPB, MNS, SS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P06028
- Gene
- GYPB
- Ensembl
- ENSG00000250361
- Chromosome
- 4
- Canonical length
- 91 aa
- Protein class
- Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
Glycophorins A (GYPA) and B (GYPB) are major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the MN and Ss blood groups. GYPB gene consists of 5 exons and has 97% sequence homology with GYPA from the 5' UTR to the coding sequence encoding the first 45 amino acids. In addition to the M or N and S or s antigens, that commonly occur in all populations, about 40 related variant phenotypes have been identified. These variants include all the variants of the Miltenberger complex and several isoforms of Sta; also, Dantu, Sat, He, Mg, and deletion variants Ena, S-s-U- and Mk. Most of the variants are the result of gene recombinations between GYPA and GYPB. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
Canonical amino-acid sequenceUniProt
91 residues, UniProt reviewed canonical sequence.
>P06028|GYPB
1 MYGKIIFVLL LSEIVSISAL STTEVAMHTS TSSSVTKSYI SSQTNGETGQ LVHRFTVPAP
61 VVIILIILCV MAGIIGTILL ISYSIRRLIK ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GYPB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 59 nTPM
- placenta: 4.5 nTPM
- spleen: 2.5 nTPM
- tongue: 0.7 nTPM
- liver: 0.4 nTPM
- lung: 0.4 nTPM
Single-cell type
- erythrocyte progenitors: 285 nCPM
- erythrocytes: 177 nCPM
- epicardial cells: 30 nCPM
- retinal ganglion cells: 12 nCPM
- cardiomyocytes: 11 nCPM
- megakaryocyte-erythroid progenitors: 3 nCPM
Immune cell
- total PBMC: 0.4 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- cerebral cortex: 4.5 nTPM
- basal ganglia: 3 nTPM
- white matter: 2.5 nTPM
- amygdala: 1.8 nTPM
- pons: 1.8 nTPM
- thalamus: 1.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.8
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.05
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GYPB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GYPB as an antibody target. Whether an autoantibody or antibody against GYPB could matter depends on whether native GYPB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GYPB is annotated at the cell surface, where native GYPB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GYPB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...